We are live on ! Find out more
TAM

Tyers Asset Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+5.29%
3 Year Est. Return
+51.12%
5 Year Est. Return
10 Year Est. Return
AUM
$3.02B
AUM Growth
+$44.2M
Cap. Flow
+$9.65M
Cap. Flow %
0.32%
Top 10 Hldgs %
25.31%
Holding
1,042
New
48
Increased
341
Reduced
261
Closed
43

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$25.1M
2
IQV icon
IQVIA
IQV
+$9.48M
3
OKE icon
Oneok
OKE
+$8.2M
4
T icon
AT&T
T
+$6.33M
5
NSP icon
Insperity
NSP
+$5.41M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$11.3M
2
CNC icon
Centene
CNC
+$10.5M
3
BNY
Bank of New York Mellon
BNY
+$8.26M
4
DRI icon
Darden Restaurants
DRI
+$4.37M
5
BEN icon
Franklin Resources
BEN
+$4.36M

Sector Composition

Rank Sector Weight
1 Technology 18.44%
2 Healthcare 18.03%
3 Financials 12.91%
4 Industrials 9.96%
5 Consumer Discretionary 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLRN
951
DELISTED
Acceleron Pharma
XLRN
$21K ﹤0.01%
528
-80
-13% -$3.47K
HALO icon
952
Halozyme
HALO
$9.2B
$20K ﹤0.01%
+1,280
New +$21.1K
PLAB icon
953
Photronics
PLAB
$1.71B
$20K ﹤0.01%
+1,804
New +$17.4K
ANDE icon
954
Andersons Inc
ANDE
$2.59B
$19K ﹤0.01%
+840
New +$21.3K
FATE icon
955
Fate Therapeutics
FATE
$318M
$19K ﹤0.01%
1,232
SPNT icon
956
SiriusPoint
SPNT
$2.92B
$19K ﹤0.01%
+1,904
New +$19.1K
IPHI
957
DELISTED
INPHI CORPORATION
IPHI
$19K ﹤0.01%
+304
New +$18.5K
MGTX icon
958
MeiraGTx Holdings
MGTX
$1.14B
$18K ﹤0.01%
+1,136
New +$26.4K
ATYR
959
aTyr Pharma
ATYR
$50.6M
$18K ﹤0.01%
5,136
-15
-0.3% -$55
ADPT icon
960
Adaptive Biotechnologies
ADPT
$3.54B
$17K ﹤0.01%
+560
New +$22.9K
EAF icon
961
GrafTech
EAF
$192M
$17K ﹤0.01%
+137
New +$16.3K
DOCU
962
DocuSign
DOCU
$10.2B
$16K ﹤0.01%
256
IOVA icon
963
Iovance Biotherapeutics
IOVA
$2.08B
$16K ﹤0.01%
880
-154
-15% -$3.41K
NET icon
964
Cloudflare
NET
$96.7B
$16K ﹤0.01%
+840
New +$16.3K
SRPT icon
965
Sarepta Therapeutics
SRPT
$1.82B
$16K ﹤0.01%
208
+64
+44% +$7.56K
STSA
966
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$16K ﹤0.01%
+1,072
New +$16.6K
CSOD
967
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$16K ﹤0.01%
286
MTSI icon
968
MACOM Technology Solutions
MTSI
$21B
$15K ﹤0.01%
+720
New +$14.1K
UPLD icon
969
Upland Software
UPLD
$15.6M
$15K ﹤0.01%
44
RETA
970
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$15K ﹤0.01%
192
CLDR
971
DELISTED
Cloudera, Inc.
CLDR
$15K ﹤0.01%
1,736
AVTR icon
972
Avantor
AVTR
$7.69B
$14K ﹤0.01%
+960
New +$16.3K
CYCN icon
973
Cyclerion Therapeutics
CYCN
$15.8M
$14K ﹤0.01%
56
FOLD
974
DELISTED
Amicus Therapeutics
FOLD
$14K ﹤0.01%
+1,680
New +$18.2K
KURA icon
975
Kura Oncology
KURA
$967M
$14K ﹤0.01%
944

Similar funds

Tyers Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Tyers Asset Management held 1,042 positions worth $3.02B, up 1.5% from $2.98B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tyers Asset Management's Q3 2019 filing shows 48 new, 341 increased, 261 reduced and 43 closed positions. Its largest new stake was iShares Russell 2000 ETF: 164,560 shares worth $24.9M. The largest sale was Oracle, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Tyers Asset Management's largest Q3 2019 buy was iShares Russell 2000 ETF: 164,560 shares worth $24.9M.
  • Tyers Asset Management added most to IQVIA in Q3 2019, an estimated $9.48M increase.
  • Tyers Asset Management's biggest Q3 2019 reduction was Oracle, cutting an estimated $11.3M.
  • Tyers Asset Management fully exited RETAIL PROPERTIES OF AMERICA, INC. in Q3 2019, selling an estimated $1.3M.
  • Tyers Asset Management's ten largest holdings make up 25% of its $3.02B portfolio in Q3 2019.
  • Tyers Asset Management opened 48 new positions and closed 43 in Q3 2019.
  • Tyers Asset Management's portfolio value rose 1.5% quarter-over-quarter to $3.02B.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.